High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome (Q78800310)
Jump to navigation
Jump to search
scientific article published on 01 January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome |
scientific article published on 01 January 2003 |
Statements
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome (English)
Feller N
Schuurhuis GJ
van der Pol MA
Westra G
Weijers GW
van Stijn A
Huijgens PC
Ossenkoppele GJ
1 January 2003